Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
Abstract Aims This study aimed to investigate the impact of baseline 6 min walk test distance (6MWTD) on time to major cardiovascular (CV) events in heart failure with reduced ejection fraction (HFrEF) and its impact in clinically relevant subgroups. Methods and results In the WARCEF (Warfarin versu...
Main Authors: | Kenji Matsumoto, Yi Xiao, Shunichi Homma, John L.P. Thompson, Richard Buchsbaum, Kazato Ito, Stefan D. Anker, Min Qian, Marco R. Di Tullio, for the WARCEF Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13068 |
Similar Items
-
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial
by: Kazato Ito, et al.
Published: (2021-12-01) -
Supervised Exercise Training Improves 6 min Walking Distance and Modifies Gait Pattern during Pain-Free Walking Condition in Patients with Symptomatic Lower Extremity Peripheral Artery Disease
by: Stefano Lanzi, et al.
Published: (2021-11-01) -
Comparison of functional ramp walk test and 6-min walk test in healthy volunteers: A new approach in functional capacity evaluation
by: Manivel Arumugam, et al.
Published: (2017-01-01) -
Walking performance in the 6-min walk test and gait speed in patients undergoing open heart surgery: A preliminary cohort study
by: Kornanong Yuenyongchaiwat, et al.
Published: (2019-01-01) -
Reference equations for 6-min walk test in healthy Indian subjects (25-80 years)
by: Ramanathan Palaniappan Ramanathan, et al.
Published: (2014-01-01)